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Brief Technique Reportsperform the combination procedure. These matters increase
the cost, and the combination procedure would not be avail-
able in most institutions. Although EUS endoscopes have
some features, such as a larger working channel (which en-
ables the use of larger needles), wider ultrasonic scanning
range, and adjustability of the protruding needle angle, the
basic mechanism is similar to that of EBUS bronchoscopes.
Use of the EBUS bronchoscope in place of the EUS endo-
scope might therefore be reasonable to simplify the proce-
dure.
In conclusion, the use of the EBUS bronchoscope in
place of the EUS endoscope for EUS–FNA in the diagno-
sis of mediastinal lesions is feasible in certain cases. This
technique allows simpler mediastinal staging with high
accuracy.From the Divisions of Cardiac Surgerya and Cardiology,b University of Pittsburgh,
Pittsburgh, Pa.
Disclosures: None.
Received for publication May 24, 2009; revisions received June 10, 2009; accepted for
publication June 10, 2009; available ahead of print Oct 9, 2009.
Address for reprints: Marco A. Zenati, MD, Professor, Division of Cardiac Surgery,
University of Pittsburgh, C700 PUH, 200 Lothrop St, Pittsburgh, PA 15213
(E-mail: zenatim@upmc.edu).
J Thorac Cardiovasc Surg 2010;139:1661-2
0022-5223/$36.00
Copyright  2010 by The American Association for Thoracic Surgery
doi:10.1016/j.jtcvs.2009.06.031
The Journal of Thoracic and CarReferences
1. Rintoul RC, Skwarski KM, Murchison JT, Wallace WA, Walker WS, Penman ID.
Endobronchial and endoscopic ultrasound-guided real-time fine-needle aspiration
for mediastinal staging. Eur Respir J. 2005;25:416-21.
2. Vilmann P, Krasnik M, Larsen SS, Jacobsen GK, Clementsen P. Transesophageal
endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) and endobron-
chial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) biopsy:
a combined approach in the evaluation of mediastinal lesions. Endoscopy. 2005;
37:833-9.
3. Wallace MB, Pascual JM, Raimondo M, Woodward TA, McComb BL, Crook JE,
et al. Minimally invasive endoscopic staging of suspected lung cancer. JAMA.
2008;299:540-6.
4. Herth FJ, Eberhardt R, Krasnik M, Ernst A. Endoesophageal ultrasound-guided
fine-needle aspiration (EUS-FNA) and endobronchial ultrasound-guided trans-
bronchial needle aspiration (EBUS-TBNA) biopsy in the evaluation of mediastinal
lesions using the EBUS-TBNA scope. Chest Meeting Abstracts. 2008;134:95003.
Available at: http://meeting.chestpubs.org/cgi/content/abstract/134/4/p95003.
5. Janes SM, Spiro SG. Esophageal endoscopic ultrasound/endobronchial ultrasound-
guided fine needle aspiration: a new dawn for the respiratory physician? Am J Re-
spir Crit Care Med. 2007;175:297-9.Subxiphoid epicardial left ventricular pacing lead placement
is feasibleTakeyoshi Ota, MD, PhD,a David Schwartzman, MD,b and Marco A. Zenati, MD,a Pittsburgh, PaCLINICAL SUMMARY
A 67-year-old woman, who had a longstanding history of
symptomatic paroxysmal atrial fibrillation (AF) with rapid
ventricular response intolerant of all pharmacotherapy,
was referred for surgical epicardial lead placement for car-
diac resynchronization therapy (CRT). Her medical history
was significant for status-post left mastectomy for breast
cancer, for which she was scheduled for left breast radiation
therapy. Also, she had a right subclavian Mediport vascular
access port (Cormed, Inc, Baltimore, Md) for chemotherapy.
Since (1) the left infraclavicular area required radiation that
precluded access for the transvenous lead placement on the
left side, (2) the right subclavian Mediport access port also
precluded access on the right side, and (3) irradiation would
compromise wound healing of classic left thoracotomy ap-
proaches (eg, minithoracotomy, video-assisted thoraco-
scopy), we decided to perform the atrioventricular (AV)node ablation followed by epicardial lead placement
through a subxiphoid approach.
After successful AV node ablation in the electrophys-
iology laboratory, a 1-inch subxiphoid incision was per-
formed and the subxiphoid cartilage was excised. The
sternum was retracted cranially with a subxiphoid retractor
(Rultract; Rultract Inc, Cleveland, Ohio) (Figure 1). The peri-
cardium was opened with stay sutures. By use of a heart po-
sitioner (Pyramid Positioner; ESTECH, San Ramon, Calif),
the heart was elevated and the posterolateral wall was ex-
posed without interfering with hemodynamic parameters
(Figure 1). Bipolar epicardial steroid-eluting leads (CapSure
Epi-model4968; Medtronic, Inc, Minneapolis, Minn) were
implanted on the posterolateral wall of the left ventricle
with 5-0 polypropylene sutures. Impedance of the left ven-
tricular lead was 602 ohms with a threshold of 2.5 V. Addi-
tional ventricular leads (Medtronic) were placed on the right
ventricle by the same technique (impedance 545 ohms with
a threshold of 2.5 V), and a pacing device (InSync III model
8042; Medtronic) was connected to these leads and im-
planted in the right upper quadrant of the abdominal wall.
The postoperative course was uneventful with no compli-
cation. At 3 months’ follow-up, both leads provided an ade-
quate synchronization for CRT and satisfactory impedance
and threshold (impedance 552 and 622 ohms with thresholds
of 1.0 V and 1.0 V), and the patient was doing well with
episodes of sinus rhythm interspersed with AF. She was
unaware of these transitions and was asymptomatic.diovascular Surgery c Volume 139, Number 6 1661
FIGURE 1. Intraoperative picture. The posterolateral wall of the left ven-
tricle is exposed with a subxiphoid sternal retractor (A) and a heart posi-
tioner (B). An epicardial lead is implanted on the posterolateral wall (C).
Brief Technique ReportsDISCUSSION
Percutaneous transvenous placement of left ventricular
leads is currently the mainstay for CRT. The percutaneous
procedure, however, can be challenging owing to a lack of
operator experience, unsuitable coronary venous distribu-
tion for CRT, and significant amount usage of contrast me-
dium and exposure to fluoroscopy. Its overall success rate is
about 90% of attempts,1 whereas suboptimal lead position-
ing occurs in 30% of ‘‘successfully placed’’ left ventricular
leads.2 The transvenous approach also involves major com-
plications such as coronary sinus perforation and/or dissec-
tion, cardiac arrest, phrenic nerve stimulation, and lead
dislodgment.
Given the limitations of percutaneous placement, surgical
approaches are becoming important for CRT. Some minimally
invasive approaches have been reported, such as video-
assisted thoracoscopy, subxiphoid videopericardioscopy,3
and a robotically assistedapproach.4 Weare interested ina sub-1662 The Journal of Thoracic and Cardiovascular Surxiphoid approach, in which there are no significant anatomic
barriers as well as no need for single-lung ventilation during
surgery. In the present case, knowing that our strategy would
lose the benefits from AV synchrony during the 30% of the
time the patient is in sinus rhythm, we believed that consistent,
drug-free ventricular rate control was critical given her very
symptomatic AF refractory to any medical therapy. The pa-
tient was scheduled for radiation therapy on the left side, and
the right subclavian vein was occupied for insertion of a Medi-
port vascular port for chemotherapy. Therefore, we believe
that this patient was a good candidate for a subxiphoid epicar-
dial left ventricular lead placement, considering that she had
no access for a percutaneous approach. A controversial topic
would be if we could place left ventricular leads in the right po-
sition. Placing left ventricular leads in adequate sites is impor-
tant to achieving hemodynamic and functional benefits of
CRT. The posterolateral wall of the left ventricle is a favorable
site for left ventricular leads to get effective hemodynamic in-
dices. A subxiphoid retractor and a heart positioner provided
a proper operative field and direct visualization of the postero-
lateral wall of the left ventricle. Although this method may not
be usable in patients with severe cardiomegaly, we believe the
subxiphoid approach can be an alternative option for surgical
epicardial left ventricular lead placement. In the future,
advanced robotic technology would expand the indication of
a subxiphoid approach for epicardial interventions, including
epicardial lead placement for CRT.5
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